BCYC
Bicycle Therapeutics Ltd
NASDAQ: BCYC · HEALTHCARE · BIOTECHNOLOGY
$4.72
-0.21% today
Updated 2026-04-30
Market cap
$337.89M
P/E ratio
—
P/S ratio
4.66x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $10
Volume
0.5M
Bicycle Therapeutics Ltd (BCYC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $2.06M | $7.14M | $13.80M | $10.39M | $11.70M | $14.46M | $26.98M | $35.27M | $72.59M |
| Revenue growth (YoY) | — | — | +246.4% | +93.4% | -24.7% | +12.6% | +23.6% | +86.5% | +30.8% | +105.8% |
| Cost of revenue | $269289.00 | $11.87M | $20.76M | $25.54M | $33.15M | $44.88M | $3.69M | $156.50M | $172.97M | $6.44M |
| Gross profit | $-269289.00 | $-9.81M | $-13.63M | $13.80M | $-22.76M | $11.70M | $14.46M | $-129.52M | $-137.69M | $72.59M |
| Gross margin | — | -476.0% | -190.9% | 100.0% | -219.0% | 100.0% | 100.0% | -480.1% | -390.3% | 100.0% |
| R&D | $9.77M | $11.87M | $20.76M | $25.54M | $33.15M | $44.88M | $81.61M | $156.50M | $172.97M | $240.28M |
| SG&A | $3.78M | $6.41M | $8.12M | $14.56M | $29.20M | $32.44M | $49.51M | $59.83M | $71.46M | $79.37M |
| Operating income | $-13.49M | $-16.21M | $-21.75M | $-26.30M | $-51.96M | $-65.62M | $-116.65M | $-189.95M | $-209.87M | $-247.06M |
| Operating margin | — | -787.0% | -304.7% | -190.6% | -500.1% | -561.0% | -806.6% | -704.1% | -595.0% | -340.4% |
| EBITDA | $-13.26M | $-15.88M | $-21.49M | $-25.34M | $-50.68M | $-64.09M | $-107.21M | $-183.40M | $-164.89M | $-276.86M |
| EBITDA margin | — | -770.9% | -301.2% | -183.6% | -487.8% | -547.9% | -741.3% | -679.9% | -467.4% | -381.4% |
| EBIT | $-13.53M | $-16.22M | $-22.20M | $-26.30M | $-51.96M | $-65.50M | $-110.90M | $-189.95M | $-172.07M | $-283.30M |
| Interest expense | $0.00 | $0.00 | $0.00 | $3.60M | $457000.00 | $2.98M | $3.34M | $3.26M | $1.73M | $206481.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.51M | $-16.26M | $-21.85M | $-30.61M | $-51.01M | $-66.82M | $-112.72M | $-180.66M | $-169.03M | $-218.96M |
| Net income growth (YoY) | — | -20.3% | -34.4% | -40.1% | -66.7% | -31.0% | -68.7% | -60.3% | +6.4% | -29.5% |
| Profit margin | — | -789.3% | -306.1% | -221.8% | -491.0% | -571.2% | -779.3% | -669.7% | -479.2% | -301.7% |